September 9, 2021

Biotalys Officially Opens New Headquarters and Research Facilities in Ghent

PDF icon
EN PDF icon
NL
August 24, 2021

Biotalys Notice of Half Year 2021 Results

PDF icon
EN
August 3, 2021

Total number of voting rights and shares

PDF icon
EN PDF icon
NL
August 2, 2021

Biotalys announces end of Stabilization Period and the partial exercise of the Over-allotment Option in respect of 712,942 Shares in connection with its Initial Public Offering

PDF icon
EN PDF icon
NL
July 15, 2021

Publication of transparency notifications

PDF icon
EN PDF icon
NL
July 6, 2021

Biotalys Appoints Markus Heldt as Independent Director

PDF icon
EN PDF icon
NL
July 5, 2021

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
July 1, 2021

Biotalys announces successful €54.6 million Initial Public Offering

PDF icon
EN PDF icon
FR PDF icon
NL
July 1, 2021

Biotalys Announces Expected Successful Closing of its Initial Public Offering

PDF icon
EN PDF icon
FR PDF icon
NL
June 29, 2021

Biotalys Announces Coverage of the Base Offering Throughout the Price Range

PDF icon
EN PDF icon
FR PDF icon
NL
June 23, 2021

Biotalys launches its Initial Public Offering on Euronext Brussels

PDF icon
EN PDF icon
FR PDF icon
NL
June 17, 2021

Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols

PDF icon
EN
June 15, 2021

Biotalys announces Intention to Launch an Initial Public Offering on Euronext Brussels

PDF icon
EN PDF icon
FR PDF icon
NL
June 10, 2021

Biotalys Nominates Catherine Moukheibir to its Board of Directors

May 4, 2021

Biotalys Earns Recognition in Fast Company’s 2021 World Changing Ideas Awards

Subscribe to our news